Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel

被引:8
作者
Cohen, D. [1 ]
Muhsen, Kh.
Aboudy, Y.
Harari, H.
Mendelson, E.
Green, M. S.
机构
[1] Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel
[2] Chaim Sheba Med Ctr, Gertner Inst, Minist Hlth, Israel Ctr Dis Control, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Cent Virol Lab, Minist Hlth, IL-52621 Tel Hashomer, Israel
关键词
rubella antibodies; outbreaks; sero-prevalence studies;
D O I
10.1016/j.vaccine.2006.04.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the prevalence of rubella antibodies in a representative sample of the Israeli population. Three thousand three hundred and twenty-six sera collected during 1997 and 1998, from an age-stratified general population sample were tested for specific IgG antibodies against rubella. The sero-positivity rates to rubella were higher among females as compared with males (89.1% versus 82.3%, respectively (p < 0.001). This difference was the result of much lower sero-positivity rates among males in the age group 13-17, with the lowest value (56.3%) among subjects aged 16. Male subjects of this age group were in 2000 the target of an outbreak of rubella among 18-19-year old male recruits of the Israel Defense Force. The data of this study served to assess previous exposure to the wild virus or vaccine strains, to identify pockets of low level of immunity and contributed to decision making in response to the onset of a rubella outbreak. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5604 / 5608
页数:5
相关论文
共 30 条
[1]   Subclinical rubella reinfection during pregnancy followed by transmission of virus to the fetus [J].
Aboudy, Y ;
Fogel, A ;
Barnea, B ;
Mendelson, E ;
Yosef, L ;
Frank, T ;
Shalev, E .
JOURNAL OF INFECTION, 1997, 34 (03) :273-276
[2]   VACCINATION AGAINST RUBELLA AND MEASLES - QUANTITATIVE INVESTIGATIONS OF DIFFERENT POLICIES [J].
ANDERSON, RM ;
MAY, RM .
JOURNAL OF HYGIENE, 1983, 90 (02) :259-325
[3]   IMMUNIZATION AND HERD-IMMUNITY [J].
ANDERSON, RM ;
MAY, RM .
LANCET, 1990, 335 (8690) :641-645
[4]   The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella [J].
Andrews, N ;
Pebody, RG ;
Berbers, G ;
Blondeau, C ;
Crovari, P ;
Davidkin, I ;
Farrington, P ;
Fievet-Groyne, F ;
Gabutti, G ;
Gerike, E ;
Giordano, C ;
Hesketh, L ;
Marzec, T ;
Morgan-Capner, P ;
Osborne, K ;
Pleisner, AM ;
Raux, M ;
Tischer, A ;
Ruden, U ;
Valle, M ;
Miller, E .
EPIDEMIOLOGY AND INFECTION, 2000, 125 (01) :127-141
[5]   Rubella [J].
Banatvala, JE ;
Brown, DWG .
LANCET, 2004, 363 (9415) :1127-1137
[6]  
BRAND N, 1983, ISRAEL J MED SCI, V19, P925
[7]  
*CDC, 1997, MMWR-MORBID MORTAL W, V46, P350
[8]   SEROLOGICAL EVIDENCE OF REINFECTION AMONG VACCINEES DURING RUBELLA OUTBREAK [J].
CUSI, MG ;
ROSSOLINI, GM ;
VALENSIN, PE ;
CELLESI, C ;
ZANCHI, A .
LANCET, 1990, 336 (8722) :1071-1071
[9]   POSSIBILITY OF REINFECTION AFTER IMMUNIZATION WITH RA27/3 LIVE ATTENUATED RUBELLA-VIRUS [J].
CUSI, MG ;
VALENSIN, PE ;
CELLESI, C .
ARCHIVES OF VIROLOGY, 1993, 129 (1-4) :337-340
[10]  
DANON YL, 1992, ISRAEL J MED SCI, V28, P733